Early warrants call expected to bring in $10.4M for InVivo

05/7/2013 | MassDevice.com (Boston)

InVivo Therapeutics is poised to obtain $10.4 million from a call for early exercise of warrants it released to investors in 2010. The call could "eliminate a major impediment towards the up-listing of the company's stock to a national securities exchange," the spinal device company said in a release.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX